openPR Logo
Press release

Oncology/Cancer Drugs Market Size to Hit USD 176,509 million by 2025: Size, Share, Development and Analysis of Key Players AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company

04-08-2019 06:25 AM CET | Health & Medicine

Press release from: Big Market Research

Oncology/Cancer Drugs

Oncology/Cancer Drugs

The global oncology/cancer drugs market was valued at $97,401 million in 2017 and is estimated to reach $176,509 million by 2025, registering a CAGR of 7.6% from 2018 to 2025.

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option to treat various cancer types, especially blood cancer (leukemia). Rise in incidence of various cancer conditions, increase in popularity of advance therapies (biological and targeted drug therapies), and surge in geriatric population worldwide are the key factors driving the growth of the global oncology/cancer drugs market. Furthermore, the rise in cancer awareness and availability of cancer drugs are expected to boost the market growth.

Request for a sample copy of this report @ https://www.bigmarketresearch.com/request-sample/22695/?utm_source=SBL

However, the high cost involved in new drug development coupled with the threat of failure & adverse effects associated with cancer drugs therapies is expected to restrain the growth of the market. Conversely, the high potential of emerging economies and an increase in the number of pipeline products are expected to provide new opportunities for market players in the future.

The global oncology/cancer drugs market is segmented based on drug class type, indication, and region. Depending on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy (biologic therapy), and hormonal therapy. By indication, it is categorized into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, and other cancers.

Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Inquiry Before Buying @ https://www.bigmarketresearch.com/purchase-enquiry/22695/?utm_source=SBL

The major players profiled in this study include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, and Pfizer Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request): Sanofi, Amgen Inc., Bayer AG and Exelixis, Inc.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Oncology/Cancer Drugs Market Key Segments:

By Drug Class Type: Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy

By Indication: Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other Cancers

By Country:

North America: U.S., Canada, Mexico

Europe: UK, Germany, France, Spain, Italy, Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific

LAMEA: Chile, Israel, South Africa, Rest of LAMEA

Access Full Summery @ https://www.bigmarketresearch.com/oncology-cancer-drugs-market/?utm_source=SBL

Similar Publisher Related report:

Global Oncology/Cancer Drugs Market 2018 by Manufacturers, Regions, Type, and Application, Forecast to 2023

More summary: https://www.bigmarketresearch.com/global-oncology-cancer-drugs-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/?utm_source=RR&utm_medium=SBL

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:

Mr. Abhishek Paliwal

 5933 NE Win Sivers Drive, #205, Portland,

 OR 97220 United States

 call answer Direct:+1-971-202-1575

 call answer Toll Free:+1-800-910-6452

 email help@bigmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology/Cancer Drugs Market Size to Hit USD 176,509 million by 2025: Size, Share, Development and Analysis of Key Players AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company here

News-ID: 1691713 • Views: 269

More Releases from Big Market Research

Transient Elastography Devices Market 2020 Analyzed by Top Key Players Echosens, …
Big Market Research provides a detailed overview of Transient Elastography Devices Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Transient Elastography Devices market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included during this report. This report is a professional and thorough research of the world Transient Elastography Devices
Augmented Reality in Retail Market Emerging Trends, Global Demand and Top Brands …
Global Augmented Reality in Retail Market is valued approximately at USD 10.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 46.6% over the forecast period 2020-2027. The Augmented Reality in Retail Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2027. The Augmented Reality in Retail market report is a valuable source of data for business strategists. It provides the industry
Aseptic Sampling Market in Global Industry: Demands, Insights, Research and Fore …
Global Aseptic Sampling Market is valued approximately USD 0.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.10 % over the forecast period 2020-2027. Big Market Research provides a detailed overview of Aseptic Sampling Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Aseptic Sampling market in conjunction with the geographical landscape,
3D Motion Capture System Market in Global Industry: Demands, Insights, Research …
The research report on 3D Motion Capture System Market thoroughly investigates historical data of this business sphere to lay out the future roadmap of the industry. The study attempts to predict a long-term picture of the market scenario with respect to the various growth indicators, hindrances, and opportunities that determine the industry expansion. Moreover, the report provides an exhaustive synopsis of the industry at a global and regional level. In

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,